Concepedia

Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study

Martin Ellis, Tsipora Neuman, Haim Bitterman, Sari Greenberg Dotan, Ariel Hammerman, Erez Battat, John W. Eikelboom, Jeffrey S. Ginsberg, Jack Hirsh

European Journal of Internal Medicine · 2016 · 29 citations · 12 references

DOI

Concepts

References

12

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

, , +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke et al. · Circulation · 2014 · 644 citations · Full text

, , +17

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Jan Beyer‐Westendorf, Kati Förster, Sven Pannach et al. · Blood · 2014 · 403 citations · Full text

, , +13

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Flemming Skjøth et al. · Journal of the American College of Cardiology · 2013 · 401 citations

, , +12